Nurix Therapeutics, Inc. (NRIX) SEC Filings & Financial Intelligence
Nurix Therapeutics, Inc. (NRIX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NRIX
CIK: 1549595
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 11/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 11/30/2019 12:00:00 AM
Lead Engagement PartnerJeffrey Zechnich
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-11-05 | — | SCHEDULE 13G/A Filing | 0000315066-26-002803 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-04 | FORM 4 | 0001817217-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001817199-26-000036 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001950047-26-010683 | View SEC Doc Filr Page |
| 144 | 2026-11-03 | — | 144 Filing | 0001950047-26-010618 | View SEC Doc Filr Page |
| 8-K | 2026-11-03 | 2026-11-03 | 8-K | 0001549595-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-30 | FORM 4 | 0001817217-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-30 | FORM 4 | 0001817199-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-30 | FORM 4 | 0001817160-26-000023 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001950047-26-010564 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-15 | FORM 4 | 0001817160-26-000021 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001950047-26-010217 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-14 | FORM 4 | 0001226675-26-000006 | View SEC Doc Filr Page |
| 10-Q | 2026-10-13 | 2026-08-31 | 10-Q | 0001549595-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-12 | 8-K | 0001549595-26-000048 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-02 | FORM 4 | 0001817199-26-000032 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001950047-26-010001 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-23 | — | SCHEDULE 13G Filing | 0001193125-26-399480 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-02 | FORM 4 | 0001817199-26-000030 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009016 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | FORM 4 | 0001817160-26-000019 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097194 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003499 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097100 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000080255-26-000570 | View SEC Doc Filr Page |